Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Dyslipidemia

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 29 articles:
HTML format
Text format



Single Articles


    August 2017
  1. POONIA A, Giridhara P
    Xanthomas in Familial Hypercholesterolemia.
    N Engl J Med. 2017;377:e7.
    PubMed     Text format    


    July 2017
  2. GAUDET D, Gipe DA, Pordy R, Ahmad Z, et al
    ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia.
    N Engl J Med. 2017;377:296-297.
    PubMed     Text format    


    April 2017
  3. RIDKER PM, Tardif JC, Amarenco P, Duggan W, et al
    Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab.
    N Engl J Med. 2017;376:1517-1526.
    PubMed     Text format     Abstract available


  4. BEIGNEUX AP, Miyashita K, Ploug M, Blom DJ, et al
    Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.
    N Engl J Med. 2017 Apr 5. doi: 10.1056/NEJMoa1611930.
    PubMed     Text format     Abstract available


    March 2017
  5. RAY KK, Landmesser U, Leiter LA, Kallend D, et al
    Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615758.
    PubMed     Text format     Abstract available


  6. RIDKER PM, Revkin J, Amarenco P, Brunell R, et al
    Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1701488.
    PubMed     Text format     Abstract available


  7. SABATINE MS, Giugliano RP, Keech AC, Honarpour N, et al
    Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615664.
    PubMed     Text format     Abstract available


    February 2017
  8. KHERA AV, Kathiresan S
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:498-9.
    PubMed     Text format    


  9. MARTIN AC, Watts GF
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:498.
    PubMed     Text format    


  10. KULLO IJ, Safarova MS
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:498.
    PubMed     Text format    


  11. HINGORANI AD, Futema M, Humphries S
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:499.
    PubMed     Text format    



  12. Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:498-500.
    PubMed     Text format    


    January 2017
  13. SCHULMAN AR, Vaidya A, Tavakkoli A, Jajoo K, et al
    Making the Connection.
    N Engl J Med. 2017;376:e5.
    PubMed     Text format    


    October 2016
  14. WALD DS, Bestwick JP, Morris JK, Whyte K, et al
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2016;375:1628-1637.
    PubMed     Text format     Abstract available


  15. MCCRINDLE BW, Gidding SS
    What Should Be the Screening Strategy for Familial Hypercholesterolemia?
    N Engl J Med. 2016;375:1685-1686.
    PubMed     Text format    


    September 2016
  16. LAMPSON BL, Gray SW, Cibas ES, Levy BD, et al
    CLINICAL PROBLEM-SOLVING. Tip of the Tongue.
    N Engl J Med. 2016;375:880-6.
    PubMed     Text format    


    May 2016
  17. CUSHMAN WC, Goff DC Jr
    More HOPE for Prevention with Statins.
    N Engl J Med. 2016;374:2085-7.
    PubMed     Text format    


    April 2016
  18. YUSUF S, Bosch J, Dagenais G, Zhu J, et al
    Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    March 2016
  19. KERSTEN S
    The Genetics of Dyslipidemia--When Less Is More.
    N Engl J Med. 2016;374:1192-3.
    PubMed     Text format    


    January 2016
  20. INGE TH, Courcoulas AP, Jenkins TM, Michalsky MP, et al
    Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents.
    N Engl J Med. 2016;374:113-23.
    PubMed     Text format     Abstract available


    October 2015
  21. EVERETT BM, Smith RJ, Hiatt WR
    Reducing LDL with PCSK9 Inhibitors--The Clinical Benefit of Lipid Drugs.
    N Engl J Med. 2015;373:1588-91.
    PubMed     Text format    


  22. SCHULMAN KA, Balu S, Reed SD
    Specialty Pharmaceuticals for Hyperlipidemia - Impact on Insurance Premiums.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


    September 2015
  23. BURTON BK, Balwani M, Feillet F, Baric I, et al
    A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency.
    N Engl J Med. 2015;373:1010-20.
    PubMed     Text format     Abstract available


    August 2015
  24. SABATINE MS, Wasserman SM, Stein EA
    PCSK9 Inhibitors and Cardiovascular Events.
    N Engl J Med. 2015;373:774-5.
    PubMed     Text format    


  25. GOEMANN IM, Londero TM, Dora JM
    PCSK9 Inhibitors and Cardiovascular Events.
    N Engl J Med. 2015;373:773-4.
    PubMed     Text format    


  26. AUER J, Berent R, Primus C
    PCSK9 Inhibitors and Cardiovascular Events.
    N Engl J Med. 2015;373:773.
    PubMed     Text format    


  27. ROBINSON JG, Kastelein JJ
    PCSK9 Inhibitors and Cardiovascular Events.
    N Engl J Med. 2015;373:774.
    PubMed     Text format    


    July 2015
  28. GAUDET D, Alexander VJ, Baker BF, Brisson D, et al
    Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia.
    N Engl J Med. 2015;373:438-47.
    PubMed     Text format     Abstract available


  29. PI-SUNYER X, Astrup A, Fujioka K, Greenway F, et al
    A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
    N Engl J Med. 2015;373:11-22.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: